Teva Pharmaceutical Industries Ltd
Company Profile
Business description
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
Contact
124 Dvora HaNevi’a Street
Tel Aviv6944020
ISRT: +972 39148213
E: TevaIR@Tevapharm.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
35,686
Stocks News & Analysis
stocks
4 stocks in Buffett's portfolio
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 7,853.70 | 60.20 | -0.76% |
| CAC 40 | 7,102.85 | 23.17 | -0.33% |
| DAX 40 | 20,374.54 | 188.19 | -0.92% |
| Dow JONES (US) | 39,405.12 | 188.54 | -0.48% |
| FTSE 100 | 7,968.84 | 55.59 | 0.70% |
| HKSE | 20,914.69 | 232.91 | 1.13% |
| NASDAQ | 16,329.41 | 57.90 | -0.35% |
| Nikkei 225 | 33,585.58 | 1,023.42 | -2.96% |
| NZX 50 Index | 12,019.13 | 182.30 | -1.49% |
| S&P 500 | 5,246.00 | 22.05 | -0.42% |
| S&P/ASX 200 | 7,646.50 | 63.10 | -0.82% |
| SSE Composite Index | 3,238.23 | 14.59 | 0.45% |